skip to main content

Biological Sciences and Healthcare, part 4

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > Clinical finding (finding) > disease > Disorder of body system > Disorder of hematopoietic structure (disorder) > Bone marrow disorder > Myeloproliferative disorder (disorder) > Myeloid leukemia > Acute myeloid leukemia > Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) > Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor
... > Clinical finding (finding) > disease > Disorder of hematopoietic cell proliferation (disorder) > Myeloproliferative disorder (disorder) > Myeloid leukemia > Acute myeloid leukemia > Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) > Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor
... > Clinical finding (finding) > disease > Neoplasm and/or hamartoma (disorder) > Neoplastic disease > Malignant tumour > Malignant neoplasm of lymphatic and haemopoietic tissue > Leukaemia > Myeloid leukemia > Acute myeloid leukemia > Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) > Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor
... > Clinical finding (finding) > disease > Neoplasm and/or hamartoma (disorder) > Neoplastic disease > Neoplasm of hematopoietic cell type (disorder) > Malignant neoplasm of lymphatic and haemopoietic tissue > Leukaemia > Myeloid leukemia > Acute myeloid leukemia > Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) > Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor
... > Clinical finding (finding) > disease > Disorder of body system > Disorder of hematopoietic structure (disorder) > Neoplasm affecting hematopoietic structure (disorder) > Leukaemia > Myeloid leukemia > Acute myeloid leukemia > Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) > Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor
... > Clinical finding (finding) > disease > Disorder of body system > Hematologic neoplasm > Neoplasm affecting hematopoietic structure (disorder) > Leukaemia > Myeloid leukemia > Acute myeloid leukemia > Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) > Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor
... > Clinical finding (finding) > disease > Neoplasm and/or hamartoma (disorder) > Neoplastic disease > Hematologic neoplasm > Neoplasm affecting hematopoietic structure (disorder) > Leukaemia > Myeloid leukemia > Acute myeloid leukemia > Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) > Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor
... > Clinical finding (finding) > disease > Neoplasm and/or hamartoma (disorder) > Neoplastic disease > Malignant tumour > Malignant neoplasm of lymphatic and haemopoietic tissue > Leukaemia > Acute leukemia > Acute myeloid leukemia > Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) > Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor
... > Clinical finding (finding) > disease > Neoplasm and/or hamartoma (disorder) > Neoplastic disease > Neoplasm of hematopoietic cell type (disorder) > Malignant neoplasm of lymphatic and haemopoietic tissue > Leukaemia > Acute leukemia > Acute myeloid leukemia > Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) > Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor
... > Clinical finding (finding) > disease > Disorder of body system > Disorder of hematopoietic structure (disorder) > Neoplasm affecting hematopoietic structure (disorder) > Leukaemia > Acute leukemia > Acute myeloid leukemia > Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) > Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor
... > Clinical finding (finding) > disease > Disorder of body system > Hematologic neoplasm > Neoplasm affecting hematopoietic structure (disorder) > Leukaemia > Acute leukemia > Acute myeloid leukemia > Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) > Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor
... > Clinical finding (finding) > disease > Neoplasm and/or hamartoma (disorder) > Neoplastic disease > Hematologic neoplasm > Neoplasm affecting hematopoietic structure (disorder) > Leukaemia > Acute leukemia > Acute myeloid leukemia > Therapy related acute myeloid leukemia and myelodysplastic syndrome (disorder) > Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor

اصطلاح مرجح

Acute myeloid leukemia and myelodysplastic syndrome related to topoisomerase type 2 inhibitor  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

مفهوم اعم

بعد از

مورفولوژی مرتبط

عامل مسبب

به دلیل

محل یافتن

هست یک

در زبان های دیگر

URI

http://www.irandoc.acir/onto/irandoc/766046007

این مفهوم را بارگیری کن:

RDF/XML TURTLE JSON-LD